c-FLIPR, a new regulator of death receptor-induced apoptosis.
about
Antioxidant c-FLIP inhibits Fas ligand-induced NF-kB activation in a phosphatidylinositol 3-kinase/Akt-dependent mannerModulation of the CD95-induced apoptosis: the role of CD95 N-glycosylationCaspases: pharmacological manipulation of cell deathElevated NF-kappaB responses and FLIP levels in leukemic but not normal lymphocytes: reduction by salicylate allows TNF-induced apoptosisFLIP the Switch: Regulation of Apoptosis and Necroptosis by cFLIPDED or alive: assembly and regulation of the death effector domain complexesRegulation of CD95/Fas signaling at the DISCGetting TRAIL back on track for cancer therapyc-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3Mechanism of procaspase-8 activation by c-FLIPLRegulation of tumour necrosis factor signalling: live or let dieMolecular architecture of the DED chains at the DISC: regulation of procaspase-8 activation by short DED proteins c-FLIP and procaspase-8 prodomainFLIP and the death effector domain familyTrailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer CellsInduction of FLIP expression by androgens protects prostate cancer cells from TRAIL-mediated apoptosisConstitutive expression of murine c-FLIPR causes autoimmunity in aged micePrimary peripheral T cells become susceptible to 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated apoptosis in vitro upon activation and in the presence of dendritic cellsEarly growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells.Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL.c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cellsChronic ethanol feeding potentiates Fas Jo2-induced hepatotoxicity: role of CYP2E1 and TNF-alpha and activation of JNK and P38 MAP kinase.Evidence of complex formation between FADD and c-FLIP death effector domains for the death inducing signaling complex.Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.The role of cellular FLICE inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer.IL-10 reduces levels of apoptosis in Toxoplasma gondii-infected trophoblasts.HBx-induced NF-κB signaling in liver cells is potentially mediated by the ternary complex of HBx with p22-FLIP and NEMO.Interleukin 7 up-regulates CD95 protein on CD4+ T cells by affecting mRNA alternative splicing: priming for a synergistic effect on HIV-1 reservoir maintenance.Emodin induces apoptosis of human cervical cancer hela cells via intrinsic mitochondrial and extrinsic death receptor pathwayApoptotic cell signaling in cancer progression and therapyThe Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious DiseasesThe regulation and role of c-FLIP in human Th cell differentiationRegulating TRAIL receptor-induced cell death at the membrane : a deadly discussionGambogic acid induces apoptosis and inhibits colorectal tumor growth via mitochondrial pathwaysThe role of c-FLIP splice variants in urothelial tumours.NF-κB Regulation of c-FLIP Promotes TNFα-Mediated RAF Inhibitor Resistance in MelanomaMurine FLIP transgene expressed on thyroid epithelial cells promotes resolution of granulomatous experimental autoimmune thyroiditis in DBA/1 mice.Regulation of chemoresistance via alternative messenger RNA splicingOn the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics.Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation.Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy.
P2860
Q23909852-13FD17A6-A7A9-4EEE-AECA-45440936E999Q24305009-7856AE63-3517-4C37-A0DF-085DC21200EEQ24536096-F72377D2-E23F-44C3-9C57-3DEA97B1E798Q24682686-73B06599-9983-4409-A542-B4035A297A0EQ26773368-88E3D911-5064-43FB-A771-C9C69B55F940Q26796544-0EB1510D-8E57-4A3D-9089-C02D90307BCFQ26824629-889C89E0-377C-47ED-9C6E-35B3EF505B23Q27027460-42524A72-6940-47FC-BE0F-50337042CFD3Q27335025-69FDA4EF-4547-42BB-9144-D7D48A128E5CQ27655368-4C9FC322-FFAA-4C0C-8C8E-7020032E7DCFQ28262381-32E745BC-A026-41B0-AC12-5C026B2C58E4Q28268989-3AE60066-89B3-4CA5-B9B6-586246BD802EQ28297969-86463969-47FE-49D1-ADC0-6F3172A245FFQ28391040-35071225-526F-4386-AE75-4B7C0719AA2EQ33363331-2267B859-91A2-4371-BE87-F2EA6FC2914AQ33654218-87B05717-4D90-4BD8-9556-CEA1C4B395BFQ33687105-CAB23C52-37E9-4A09-A3A7-A1BC881A5F48Q33723716-907B544F-E5BA-4404-97F2-F4B7E926E0D7Q34069986-5402FA5B-C567-46DC-99B9-D058C99FED78Q34139663-48788D00-D9A7-4E74-9F96-9D82C530BDFFQ34252014-54583C86-89A0-47D5-939A-BA74A7E48F52Q34389751-ACB39925-D4EF-41C0-9BEC-EF88BF963151Q34427649-82D2E018-D507-400C-BC0B-B2619DD22D60Q34488806-CD1F0584-0D7C-4489-B56F-A6585E81FF6BQ34590090-930FBF0C-9B88-445A-8027-31428A697A0AQ34618294-80EA80ED-84FF-4968-B1CE-CB9C0E124EA5Q34801476-1FC9531F-A238-43B9-9E04-4EB1D8554218Q34834121-6AB74941-87B9-4642-B5F2-28A5B194FAC9Q35088734-ED7A797A-0CE7-46C6-83C4-D180BB04BD04Q35172090-0D2F619B-7385-459C-92BC-B8A81AF69CF0Q35206314-871C2899-42A8-4BA5-94FC-02BAD8910BB7Q35480734-E14EFB2B-3CD2-4548-8CC4-7EB07DB8D2DDQ35649530-54BD75EB-0EAC-4A8E-BE74-49C6C58BB79EQ35657114-E264BFA4-F60C-4A25-B468-B92CAE52FBC0Q35738534-6AB34ED7-DA5A-4ADE-BD10-804B7EB84BCFQ35781415-2CD5EABD-4265-4B7F-9E2A-B5F85D731DBEQ35822883-CD65FEB8-8023-422E-9C3B-E7825FE29A61Q35853714-93E85C0C-9F99-4FF9-9367-6A22FCB3B5B2Q35906438-566894B9-1AFB-4C39-85F8-319242846241Q35915103-0A30880A-FA50-444E-BA21-B5FC262ED5CD
P2860
c-FLIPR, a new regulator of death receptor-induced apoptosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
c-FLIPR, a new regulator of death receptor-induced apoptosis.
@en
type
label
c-FLIPR, a new regulator of death receptor-induced apoptosis.
@en
prefLabel
c-FLIPR, a new regulator of death receptor-induced apoptosis.
@en
P2093
P356
P1476
c-FLIPR, a new regulator of death receptor-induced apoptosis
@en
P2093
Alexander Golks
Cornelius Fritsch
Inna N Lavrik
Peter H Krammer
P304
14507-14513
P356
10.1074/JBC.M414425200
P407
P50
P577
2005-02-08T00:00:00Z